Meeder Asset Management Inc Unity Biotechnology, Inc. Transaction History

Meeder Asset Management Inc

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2020 Aug 11, 2020	SELL	$5.28 - $9.67 $1,029 - $1,885	-195 Closed	0 $0
Q1 2020 May 15, 2020	SELL	$5.0 - $7.6 $410 - $623	-82 Reduced 29.6%	195 $1,000
Q3 2019 Oct 17, 2019	SELL	$5.62 - $9.63 $1,079 - $1,848	-192 Reduced 40.94%	277 $2,000
Q2 2019 Aug 05, 2019	BUY	$7.59 - $10.21 $3,559 - $4,788	469 New	469 $4,000

4.41M

Ticker UBX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 14,036,200
Market Cap $16.1M
Description
Unity Biotechnology, Inc., a biotechnology company, engages in the research and development of therapeutics to slow, halt, or reverse diseases of aging. The company's lead drug candidate includes UBX1325, which is Phase II clinical trial for the treatment of age-related diseases of the eye, including diabetic macular edema, age-related macular d...

Get notified when there are updates to the investment portfolio of Meeder Asset Management Inc, based on Form 13F filings with the SEC.

Stay updated on Meeder Asset Management Inc with notifications on news.